MedPath

Stem cell trial of recovery enhancement after stroke 3

Not Applicable
Completed
Conditions
Topic: Stroke Research Network
Subtopic: Rehabilitation
Disease: Community study
Circulatory System
Sequelae of stroke
Registration Number
ISRCTN16714730
Lead Sponsor
niversity of Nottingham (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Adults (18 years and over)
2. Male and female participants
3. Motor impairment (arm or leg) with residual disability (modified Rankin Score >1) due to stroke >90 days post onset.

Exclusion Criteria

1. Lack of residual motor deficit
2. Significant cognitive impairment that will impede ability to complete assessments
3. Diagnosis likely to interfere with outcome or rehabilitation (e.g. terminal illness)
4. Still receiving post stroke rehabilitation
5. Pregnancy
6. Other exclusions of GCSF (as per British National Formulary)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Feasibility<br>2. Proportion of participants receiving all 5 GCSF/ placebo injections<br>3. Proportion of participants receiving all 18 therapy sessions
Secondary Outcome Measures
NameTimeMethod
1. Acceptability<br>2. Proportion of participants screened who are eligible for enrollment who give consent<br>3. Tolerability<br>4. Adverse events (headache, backache) reported after G-CSF administration<br>5. Secondary Haematological (FBC, WCC, CD34, PLT)<br>6. Post therapy intervention (day 45 and, end of follow-up day 90): <br>6.1. Motor function (RMA)<br>6.2. Change in dependency (modified Rankin Scale shift)<br>6.3. Change in disability (change in BI)<br>6.4. Quality of life (EuroQoL)<br>6.5. Care giver burden
© Copyright 2025. All Rights Reserved by MedPath